Investment Summary

Telegraph Hill Partners Invests In ObservSMART

On March 29, 2019, venture capital firm Telegraph Hill Partners invested in medical products company ObservSMART

Investment Highlights
  • This is Telegraph Hill Partners’ 16th transaction in the Medical Products sector.
  • This is Telegraph Hill Partners’ 26th transaction in the United States.
  • This is Telegraph Hill Partners’ 1st transaction in Pennsylvania.

Investment Summary

Date 2019-03-29
Target ObservSMART
Sector Medical Products
Investor(s) Telegraph Hill Partners
Deal Type Venture

Target

ObservSMART

West Chester, Pennsylvania, United States
ObservSMART provides pioneering products that solve the problems associated with high-reliability patient monitoring for high-risk patient populations. ObservSMART is based in West Chester, Pennsylvania.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Telegraph Hill Partners

San Francisco, California, United States

Investor Investor Investor Investor Investor


Category Venture Capital Firm
Founded 2001
Size Middle-Market
Type Sector Focused
DESCRIPTION

Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.


DEAL STATS #
Overall 29 of 33
Sector (Medical Products) 16 of 17
Type (Venture) 17 of 20
State (Pennsylvania) 1 of 1
Country (United States) 26 of 30
Year (2019) 2 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-01 Teknova

Hollister, California, United States

Teknova is a manufacturer and sells cell culture media and buffers into the research and bioproduction markets. Teknova is based in Hollister, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-30 Nimble Therapeutics

Madison, Wisconsin, United States

Nimble Therapeutics is a provider of massively parallel chemical synthesis to drug discovery. Nimble’s proprietary technology enables the synthesis and screening of millions of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. Nimble Therapeutics was founded in 2019 and is based in Madison, Wisconsin.

Buy -